Space exploration involves challenges for an extended human presence. The space environment exposes the human body to a unique combination of physical and psychological stressors. Most noteworthy are the effects of microgravity and high charge/high energy (HZE) particle radiation with a potential for hypoxia (in off-nominal situations), occasional hyperoxia, dietary restrictions, and possible nutritional deficiencies as significant hazardous confounding factors (Sonnenfeld et al., 2003; Taibbi et al., 2013; Taylor et al., 2013; Sides et al., 2005; Mader et al., 1999; Planel et al., 1989; Reitz et al., 2009; Cucinotta et al., 2001; Cucinotta et al., 2008). Microgravity induces cephalad fluid shifts and physical unloading, leading to deleterious effects such as muscle atrophy, loss of bone mass, cardiovascular alterations, postflight orthostatic intolerance, and immunosuppression (Pietsch et al., 2011; Sundaresan and Pellis, 2009; Blaber et al., 2013). More recently, ocular changes associated with spaceflight have been reported in astronauts exhibiting alterations in near visual acuity and other ocular-based signs and symptoms (Alexander et al., 2012). These medical data describe evidence of optic disc edema, choroidal folds and posterior globe flattening, hyperoptic shift in vision, optic nerve sheath distension, and in some cases, optic nerve kinking and empty sella (Kramer et al., 2012; Mader et al., 2011), possibly associated with intracranial pressure increase. Identifying causative factors and investigating microgravity’s influence as a source of stress for the eye have acquired importance.
Previous basic research investigating the effects of spaceflight on eye structures and general ocular health is scarce and limited to basic histopathology on space-flown animal models (Marshall-Bowman et al., 2013). Neonatal rats flown for nine days onboard the Space Shuttle mission STS-72 displayed clear evidence of retinal degeneration (Tombran-Tink and Barnstable, 2006). In another study, adult rats flown onboard Russian Cosmos satellites for approximately 14 days exhibited cellular swelling in the retina and retinal disruption (Philpott et al., 1980).
Recently, our group investigated the effects of spaceflight on the eyes of mice flown onboard Space Shuttle mission STS-133 and, for the first time, reported molecular and cellular changes correlating to the histopathologic outcomes (Zanello et al., 2013). Flight samples from that study stained positive for β-amyloid and glial fibrillary acidic protein (GAFP) in the optic nerve. Retina from mice flown on STS-133 also showed increased levels of 8-hydroxy-2’-deoxyguanosine (8OHdG), an oxidized form of guanosine that serves as a standard biomarker of oxidative DNA damage, and of caspase-3 immunoreactivity, suggesting an early step both in the extrinsic (death ligand) and intrinsic (mitochondria) apoptosis pathway. In addition, upregulated levels of oxidative and cellular stress response genes were detected. Herein, we report the findings of a subsequent animal experiment onboard STS-135 in which we expanded the molecular aspects of the impact of spaceflight on retinal biology by performing differential gene expression profiling between mice flown onboard STS-135 and their ground control counterparts.
This work is the result of a tissue sharing effort that utilized specimens collected from a parent animal experiment onboard STS-135. Animal procedures were approved by the NASA Ames Research Center and Kennedy Space Center institutional animal care and use committees. Mice were flown onboard STS-135 that lifted off at 11:29 a.m. EDT on July 8, 2011 and landed at 5:57 a.m. on July 21, 2011. The mission duration was 12 days, 18 hours, and 28 minutes.
Male 9 to 11 week-old C57BL/6 mice were assigned to one of two experimental groups: Flight (FLT) and Animal Enclosure Module (AEM) ground controls. Both eyes from three animals for each group (n=3) were used in this study, one for gene expression analysis and the other for histology. The flight animals were housed in AEMs identical to the ground controls, and our analysis focuses on the comparison between these two conditions. The AEM is a self-contained habitat that provides ventilation, waste management, food, water, and controlled lighting (Naidu et al., 1995), and has previously been used in experiments studying rodent biology during spaceflight. The AEM was located in the middeck locker of the Space Shuttle, and the temperature was set at 3 to 8°C above the environmental middeck temperature. Lighting of 14 lux was set to a 12 hour day/12 hour night cycle for both FLT and AEM habitats.
After euthanasia at day one of landing, one eye of each mouse was enucleated and fixed for histologic examination. The contralateral eye was placed in RNA preservative (RNAlater®) until further dissection, which was performed by making an incision by scalpel to separate the posterior eye cup, removing the lens and vitreous and carefully scraping the retina. The retina was then placed again in RNAlater® and processed for gene expression profiling by microarray analysis as described below.
A 4% paraformaldehyde-based histologic fixative was obtained from Excalibur Pathology, Inc., Oklahoma City, OK. Goat polyclonal antibody to 8-hydroxy-2’-deoxyguanosine (8-OHdG) (ab10802) and rabbit polyclonal antibody to activated caspase-3 (ab52181) were purchased from Abcam Inc., Cambridge, MA. Paraffin embedding and histological sectioning were contracted from Excalibur Pathology. RNA isolation reagents were purchased from Qiagen Inc., Valencia, CA and BioRad, Hercules, CA. Tissue samples were assigned a different number for immunohistochemistry evaluation and gene profiling in order to perform a masked analysis.
Fixed eyes were paraffin embedded, sectioned at 5 μm thickness, and stained with standard hematoxylin-eosin (H&E) for histologic examination. Two immunohistologic stains were performed: 8OHdG to detect oxidative-related DNA damage and activated caspase-3 to study apoptosis. For 8OHdG and caspase-3 staining, sections were equilibrated in water after deparaffinization and treated sequentially in 3% hydrogen peroxide, 1% acetic acid, and 2.5% serum (Vector Labs, Burlingame, CA) before incubating with the diluted primary antibody for either two hours at room temperature or overnight at 4°C. After washing, the specimens were incubated with Vector ImmPress detection kit, corresponding to the primary antibody’s host and counterstained with hematoxylin.
A qualitative approach was used to compare apoptosis in the retina. Activated caspase-3 positive cells were identified for the retinal ganglion cell (RGC) layer in a retina section for each sample. The histologic sections were cut in the proximity of the optic nerve head for better comparison.
Estimation of the 8OHdG immunoreactivity was done using ImageJ software (masked for specific study groups) on 8OHdG stained slides. Briefly, digital color images of the retina were processed using NIH ImageJ ver.1.68 (NIH) and converted to an 8-bit inverted grayscale image for analysis. Regions of interest were selected from each retinal section, corresponding to the RGC layer, inner nuclear layer (INL), and outer nuclear layer (ONL), as well as nearby areas without immunoreactivity for background measurements. Five sections were analyzed for each sample, for which the mean density per unit area (minus mean background density) was measured. A 2-tailed
Mouse retina was microdissected and isolated from the rest of the eye and then placed again in RNAlater®. Total RNA was then isolated from the retina using the AllPrep DNA/RNA Micro kit (Qiagen, Valencia, CA) and analyzed for quality using an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA). All samples used reported a RNA Integrity Number (RIN) >6.0 and were confirmed to have 2 sharp bands/peaks representing the 28s and 18s RNA. Some variability in the RIN among samples was observed, presumably due to a handling delay in sample processing that derived from reasons out of our control, which caused the samples to remain in RNAlater® at 4°C for four months before dissection of the retina. Microarray gene expression analysis was performed at the University of Texas Medical Branch (UTMB) at Galveston Molecular Genomics Core using Affymetrix Mouse 430 2.0 GeneChip (Affymetrix, Inc., Santa Clara, CA) with Affymetrix Expression Console and Transcriptome Analysis Console for secondary analysis. An Ingenuity iReport (Ingenuity Systems, Redwood City, CA) was then generated for canonical pathway identification. Two-way (gene and sample) hierarchical cluster analysis was performed on log-transformed, median-centered, and normalized signals from the FLT and AEM ground control samples. Normalized expression values were obtained using the Robust Multichip Analysis (RMA) algorithm. Results were visualized with the Transcriptome Analysis Console software 1.0.0.234 (Affymetrix, Inc.) using a cut-off
Caspase-3 immunoreactivity was moderate and localized mostly in some RGCs. Caspase-3 positive cells in the RGC layer showed intense cytoplasmic and neurite staining, particularly in the FLT samples. Representative images are present in Figure 1 (Panels A and B) with arrows pointing to localized Caspase staining. Higher magnification views are shown for the AEM (panel C) and FLT (panel D) in Figure 1. We observed signs of retinal disruption at the level of the photoreceptors and INL, with vacuolization and cell swelling.
To quantify oxidative DNA damage in the retina, densitometric quantification of 8OHdG immunohistochemistry was performed on eye sections (n=3/group), as presented in Figure 2. A statistically significant increase in 8OHdG was detected in the INL between the FLT and AEM ground control groups. 8OHdG intensity levels were not shown to be statistically different in the ONL and the RGC between FLT samples and AEM ground controls.
Microarray analysis was performed using the Mouse Expression Set 430 microchip, which allows the independent multi-probe detection of over 39,000 transcripts on a single array. Using the analytical parameters specified in the Methods section, 139 differentially expressed genes were identified in FLT retina samples compared to AEM controls (at least 1.5-fold expression change,
Symbol: Name | Fold Change | Molecular Function |
---|---|---|
DSP: desmoplakin | 4.01 | other |
LY6E: lymphocyte antigen 6 complex, locus E | 2.95 | other |
LCN2: lipocalin 2 | 2.75 | transporter |
SLC44A2: solute carrier family 44, member 2 | 2.55 | transporter |
CIRBP: cold inducible RNA binding protein | 2.48 | translation regulator |
POU4F1: POU class 4 homeobox 1 | 2.44 | transcription regulator |
SGMS2: sphingomyelin synthase 2 | 2.36 | enzyme |
Defb9: defensin beta 9 | 2.36 | other |
RIPK4: receptor-interacting serine-threonine kinase 4 | 2.32 | kinase |
RPRD2: regulation of nuclear pre-mRNA domain containing 2 | 2.15 | other |
PAQR8: progestin and adipoQ receptor family member VIII | 2.04 | other |
1700019G17Rik/Cml2: camello-like 2 | 1.99 | other |
CUL2: cullin 2 | 1.98 | enzyme |
ALCAM: activated leukocyte cell adhesion molecule | 1.96 | other |
ZBTB16: zinc finger and BTB domain containing 16 | 1.95 | transcription regulator |
CLVS1: clavesin 1 | 1.93 | other |
ZC3H6: zinc finger CCCH-type containing 6 | 1.92 | other |
B4GALNT1: beta-1,4-N-acetyl-galactosaminyl transferase 1 | 1.92 | enzyme |
GNA13: guanine nucleotide binding protein (G protein), alpha 13 | 1.89 | enzyme |
CTSH: cathepsin H | 1.87 | peptidase |
WFS1: Wolfram syndrome 1 | 1.84 | enzyme |
HNRPDL: heterogeneous nuclear ribonucleoprotein D-like | 1.84 | other |
PARP12: poly (ADP-ribose) polymerase family, member 12 | 1.83 | other |
EHD4: EH-domain containing 4 | 1.82 | enzyme |
ACOT9: acyl-CoA thioesterase 9 | 1.81 | enzyme |
AGXT2L1: alanine-glyoxylate aminotransferase 2-like 1 | 1.80 | enzyme |
SH3YL1: SH3 domain containing, Ysc84-like 1 | 1.80 | other |
2210403K04Rik: RIKEN cDNA 2210403K04 gene | 1.79 | other |
INPP1: inositol polyphosphate-1-phosphatase | 1.79 | phosphatase |
SLC39A4: solute carrier family 39 (zinc transporter), member 4 | 1.79 | transporter |
ZSCAN21: zinc finger and SCAN domain containing 21 | 1.79 | transcription regulator |
CMAS: cytidine monophosphate N-acetylneuraminic acid synthetase | 1.77 | enzyme |
KALRN: kalirin, RhoGEF kinase | 1.76 | kinase |
RUFY2: RUN and FYVE domain containing 2 | 1.76 | other |
TRIM25: tripartite motif containing 25 | 1.76 | transcription regulator |
ANGPTL4: angiopoietin-like 4 | 1.74 | other |
CHST15: carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 | 1.73 | enzyme |
PEX13: peroxisomal biogenesis factor 13 | 1.72 | transporter |
MKRN1: makorin ring finger protein 1 | 1.72 | other |
A2M: alpha-2-macroglobulin | 1.72 | transporter |
MRPL15: mitochondrial ribosomal protein L15 | 1.71 | other |
FABP4: fatty acid binding protein 4, adipocyte | 1.71 | transporter |
AI451250: expressed sequence AI451250 | 1.69 | other |
KRT23: keratin 23 (histone deacetylase inducible) | 1.69 | other |
FKBP5: FK506 binding protein 5 | 1.69 | enzyme |
FAM194A: family with sequence similarity 194, member A | 1.66 | other |
MFSD6: major facilitator superfamily domain containing 6 | 1.66 | other |
Gm9776: predicted gene 9776 | 1.66 | other |
SDR42E1: short chain dehydrogenase/reductase family 42E, member 1 | 1.66 | enzyme |
A930041H05Rik: RIKEN cDNA A930041H05 gene | 1.65 | other |
TXNRD3: thioredoxin reductase 3 | 1.65 | enzyme |
Pax6os1: Pax6 opposite strand transcript 1 | 1.65 | other |
SLC1A1: solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter), member 1 | 1.64 | transporter |
COL19A1 (includes EG:12823): collagen, type XIX, alpha 1 | 1.63 | other |
GPCPD1: glycerophosphocholine phosphodiesterase GDE1 homolog (S. cerevisiae) | 1.62 | other |
LGI1: leucine-rich, glioma inactivated 1 | 1.62 | other |
DCXR: dicarbonyl/L-xylulose reductase | 1.62 | enzyme |
SBSN: suprabasin | 1.62 | other |
NIPSNAP1: nipsnap homolog 1 (C. elegans) | 1.61 | enzyme |
SMC6: structural maintenance of chromosomes 6 | 1.61 | other |
REPS2: RALBP1 associated Eps domain containing 2 | 1.60 | other |
HIST2H2AA3/HIST2H2AA4: histone cluster 2, H2aa3 | 1.60 | other |
CRISPLD2: cysteine-rich secretory protein LCCL domain containing 2 | 1.59 | other |
SORL1: sortilin-related receptor | 1.59 | transporter |
WWC1: WW and C2 domain containing 1 | 1.59 | transcription regulator |
DHCR24: 24-dehydrocholesterol reductase | 1.59 | enzyme |
ACSL5: acyl-CoA synthetase long-chain family member 5 | 1.59 | enzyme |
SMOX: spermine oxidase | 1.58 | enzyme |
CHCHD7: coiled-coil-helix-coiled-coil-helix domain containing 7 | 1.58 | other |
NT5C2: 5’-nucleotidase, cytosolic II | 1.58 | phosphatase |
CPNE8: copine VIII | 1.58 | other |
TCTA: T-cell leukemia translocation altered gene | 1.58 | other |
PLEKHH1: pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 | 1.57 | other |
Rbpms: RNA binding protein gene with multiple splicing | 1.57 | transcription regulator |
TTLL11: tubulin tyrosine ligase-like family, member 11 | 1.57 | other |
FEM1C: fem-1 homolog c (C. elegans) | 1.57 | transcription regulator |
PLIN4: perilipin 4 | 1.57 | other |
CDA: cytidine deaminase | 1.57 | enzyme |
IFI35: interferon-induced protein 35 | 1.56 | other |
UGT1A6: UDP glucuronosyltransferase 1 family, polypeptide A6 | 1.56 | enzyme |
D130037M23Rik: RIKEN cDNA D130037M23 gene | 1.56 | other |
SLC7A1: solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | 1.56 | transporter |
SNRPD3: small nuclear ribonucleoprotein D3 polypeptide 18kDa | 1.55 | other |
TSC22D3: TSC22 domain family, member 3 | 1.55 | other |
KAZN: kazrin, periplakin interacting protein | 1.55 | other |
SH3BP5: SH3-domain binding protein 5 (BTK-associated) | 1.55 | other |
CHL1: cell adhesion molecule with homology to L1CAM | 1.54 | other |
HNRNPD: heterogeneous nuclear ribonucleoprotein D | 1.54 | transcription regulator |
PLIN2: perilipin 2 | 1.54 | other |
PTGIS: prostaglandin I2 (prostacyclin) synthase | 1.53 | enzyme |
ARMCX5: armadillo repeat containing, X-linked 5 | 1.53 | other |
TNFAIP2: tumor necrosis factor, alpha-induced protein 2 | 1.53 | other |
BRD8: bromodomain containing 8 | 1.53 | transcription regulator |
BTBD11: BTB (POZ) domain containing 11 | 1.53 | transcription regulator |
PHYHIP: phytanoyl-CoA 2-hydroxylase interacting protein | 1.53 | other |
RBM3: RNA binding motif (RNP1, RRM) protein 3 | 1.52 | other |
HAGHL: hydroxyacylglutathione hydrolase-like | 1.51 | enzyme |
MARVELD2: MARVEL domain containing 2 | 1.51 | other |
WWP2: WW domain containing E3 ubiquitin protein ligase 2 | 1.51 | enzyme |
DIS3: DIS3 mitotic control homolog (S. cerevisiae) | 1.51 | enzyme |
ZBTB22: zinc finger and BTB domain containing 22 | 1.51 | other |
CYB561: cytochrome b-561 | 1.51 | enzyme |
RNF208: ring finger protein 208 | 1.51 | other |
FAM122B: family with sequence similarity 122B | 1.51 | other |
UPK3B: uroplakin 3B | 1.51 | other |
C6orf115: chromosome 6 open reading frame 115 | 1.50 | other |
MARCH7: membrane-associated ring finger (C3HC4) 7 | 1.50 | other |
HSPH1: heat shock 105kDa/110kDa protein 1 | -1.51 | other |
LOC100505793/SRSF10: serine/arginine-rich splicing factor 10 | -1.51 | other |
LIMA1: LIM domain and actin binding 1 | -1.53 | other |
KDM2A: lysine (K)-specific demethylase 2A | -1.53 | other |
CREBZF: CREB/ATF bZIP transcription factor | -1.54 | transcription regulator |
CRELD2: cysteine-rich with EGF-like domains 2 | -1.54 | other |
BCAS2: breast carcinoma amplified sequence 2 | -1.54 | other |
DYNLL1: dynein, light chain, LC8-type 1 | -1.55 | other |
BB116930: expressed sequence BB116930 | -1.55 | other |
SRSF6: serine/arginine-rich splicing factor 6 | -1.56 | other |
CHORDC1: cysteine and histidine-rich domain (CHORD) containing 1 | -1.57 | other |
PUM2: pumilio homolog 2 (Drosophila) | -1.59 | other |
HIST3H2A: histone cluster 3, H2a | -1.61 | other |
TRPM1: transient receptor potential cation channel, subfamily M, member 1 | -1.62 | ion channel |
TRIM47: tripartite motif containing 47 | -1.62 | other |
4931428L18Rik: RIKEN cDNA 4931428L18 gene | -1.63 | other |
XBP1 (includes EG:140614): X-box binding protein 1 | -1.65 | transcription regulator |
HIST1H3A: histone cluster 1, H3a | -1.66 | other |
HSPA5: heat shock 70kDa protein 5 | -1.69 | enzyme |
6530402F18Rik: RIKEN cDNA 6530402F18 gene | -1.70 | other |
ARSI: arylsulfatase family, member I | -1.70 | enzyme |
NECAB1: N-terminal EF-hand calcium binding protein 1 | -1.73 | other |
CPSF6: cleavage and polyadenylation specific factor 6, 68kDa | -1.73 | other |
BTG1: B-cell translocation gene 1, anti-proliferative | -1.74 | transcription regulator |
HIST2H3C (includes others): histone cluster 2, H3c | -1.79 | other |
CA8: carbonic anhydrase VIII | -1.79 | enzyme |
C430048L16Rik/Rbm12b: RIKEN cDNA C430048L16 gene | -1.89 | other |
TRA2A: transformer 2 alpha homolog (Drosophila) | -2.10 | other |
MALAT1: metastasis associated lung adenocarcinoma transcript 1 | -2.15 | other |
S1PR3: sphingosine-1-phosphate receptor 3 | -2.26 | G-protein coupled receptor |
SFPQ: splicing factor proline/glutamine-rich | -2.33 | other |
SLC5A3: solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | -2.64 | transporter |
Relevant gene expression changes were organized and filtered biologically and functionally by pathway analysis tools based on the Ingenuity Knowledge Base, a repository of curated biological interactions and functional annotations. The pathways were generated through the use of Ingenuity® iReport (Ingenuity® Systems,
PATHWAYS | PROCESSES | DISEASES |
---|---|---|
Endoplasmic Reticulum (ER) stress | RNA processing (mRNA splicing) | Molecular mechanisms of cancer |
Pyrimidine metabolism RGC | Cell death of sensory neurons and nervous tissue | Neurodegeneration of nerves and |
Cytokine production and signaling (IL-1, IL-6, IL17) | Apoptosis of microglia and neuronal cells | Degeneration of the optic nerve |
Sphingosine-1-P signaling | Stabilization and assembly of desmosomes | Reactivation of herpes virus |
Axonal guidance and actin cytoskeleton | Axon branching |
Our work explores the possible effects of the spaceflight environment on retinal biology, in an effort to shed light on the confounding factors and processes that may contribute to vision risks in space. Corollary to a previous report on the effects of spaceflight on the retina of BALB/cJ mice (Zanello et al., 2013), we now report results of a similar experiment carried out on C57BL mice onboard STS-135. The main findings in this work demonstrate evidence of increased oxidative stress-DNA damage, histological changes, as well as potential effects of spaceflight on retinal biology based on microarray gene expression profiling. Similar results have been reported by an independent group (Mao et al., 2013); however, the gene expression profiling performed in the cited work originated from non-dissected eyes that included all eye tissues and structures. The eye is a complex organ with a heterogeneous tissue composition due to its various structures: sclera, cornea, retina, lens, choroid, retina microvasculature, aqueous humor production, and drainage system. Therefore, gene expression derived from the entire eye globe does not precisely reflect the tissue of origin of the genetic responses. Our work presents, for the first time, comparative whole genome expression profiling of retinas dissected from mice exposed to spaceflight and their ground controls. Even in this case, we must bear in mind that the retina is composed of various cell types from both neural and vascular cellular populations.
A number of activated caspase-3 positive cells were observed, in particular, in the RGC layer of FLT samples, but due to the limitation in the number of sections, our examination was limited to a qualitative comparison. Overall, caspase-3 immunoreactivity in the FLT samples was observed to be localized at moderate levels in the RGC, with light levels seen throughout the photoreceptor inner segments. Of note, cytological alterations in the photoreceptor layer from FLT mice in this study were in line with previous reports in the literature of spaceflight induced damage to the ganglion cell layer and disruption of the plexiform layers and photoreceptors of rat neonates (Tombran-Tink and Barnstable 2006). Quantification of 8OHdG immunoreactivity showed statistically significant (
Pathway analysis derived from differential gene expression of microarray data revealed processes related to neuronal and glial cell loss, mechanisms of apoptosis, and ER stress. Evidence supporting these processes included, among others, the downregulation (-1.65 fold FLT vs. AEM) of XBP1, a potent transcription factor involved in the unfolded protein response (UPR). Processing of XBP1 mRNA is an obligate step in the UPR pathway and the IRE1/XBP-1 pathway is required for efficient protein folding, maturation, and degradation in the ER (Calfon et al., 2002; Lee et al., 2002; Sriburi et al., 2004). In addition, Hspa5, a member of the Hsp70 family that also resides in the ER and participates in protein folding, was also downregulated -1.69 fold, in agreement with a possible impairment of the ER stress response, which other studies have linked to increased susceptibility to Alzheimer’s disease (Hebert and Molinari 2007; Guzel et al., 2011; Hsu et al., 2008). A result of cellular insults that cause prolonged ER stress include apoptosis through caspase-7-mediated caspase-12 activation and lead to neuronal and glial cell loss (Nakagawa et al., 2000; Szegezdi et al., 2003).
Interestingly, XBP1 is also implicated in processes related to the reactivation of herpes virus (Lawson et al., 2008; Dalton-Griffin et al., 2009; Wilson et al., 2007). It is well known that virus reactivation is a common phenomenon associated with spaceflight, but the mechanisms leading to it are not understood (Brinley et al., 2013; Mehta et al., 2000; Mehta et al., 2004; Stowe et al., 2001). We must bear in mind that the retina is mostly composed of neural cells and that the herpes virus is neurotropic. A putative implication of XBP1 as a transcription factor crucial in the protection against viral reactivation in space is not implied, but could be further investigated to shed some light into possible targets for mitigation against the risk of viral reactivation in space.
Other differentially expressed genes between FLT and AEM retinas suggested pathways of neuronal cell loss and degeneration. SLC1A1, a member of the high-affinity glutamate transporters that play an essential role in transporting glutamate across plasma membranes, was upregulated +1.64 in FLT compared to AEM retinas. In the brain, these transporters are crucial in terminating the postsynaptic action of the neurotransmitter glutamate and in maintaining extracellular glutamate concentrations below neurotoxic levels (Sheldon and Robinson 2007; Deng et al., 2007; Arnold et al., 2006). It has also been shown to be involved in RGC death (Martins et al., 2006; Sheldon and Robinson, 2007) and its upregulation in FLT samples may suggest that glutamate level increase may be associated with space environmental factors. Concurrently, the transporter lipocalin 2 (LCN2) showed a marked upregulation of +2.75 fold in the FLT group. LCN2 has been shown in the literature to be related to inflammation in the retina following ischemia-reperfusion injury (Abcouwer et al., 2013) and may serve a similar role in modulating an inflammatory response to spaceflight.
Beta-amyloid deposits have previously been suggested as related to RGC and optic nerve degeneration (Zanello et al., 2013). Alpha-2-macroglobulin (A2M) inhibits many proteases, including trypsin, thrombin, and collagenase and is implicated in Alzheimer disease due to its ability to mediate the clearance and degradation of A-beta, the major component of beta-amyloid deposits (Liao et al., 1998; Blacker et al., 1998). Our results show that A2M was induced +1.72 fold in FLT compared to ground AEM, possibly suggesting the triggering of clearance mechanisms to reduce an increase in any deposits.
The RNA used in this study originated from dissected retina containing a mixed cell type population. While the major representation is of neural cells of various types, it is expected that some relevant genes were represented due to their expression in other retinal cell types. Endothelial cells from the retinal microvasculature are one example. S1PR3 encodes a member of the EDG family of receptors, which are G-protein coupled receptors (Crousillac et al., 2009). This protein has been identified as a functional receptor for sphingosine 1-phosphate and likely contributes to the regulation of angiogenesis and vascular endothelial cell function (Sanchez et al., 2007; Daum et al., 2009). We observed a significant downregulation of -2.26 fold in FLT retinas versus AEM, a change that may suggest vascular remodeling could be taking place in conjunction with some degree of retinal degeneration and neural remodeling and should be investigated in future studies. Changes in the expression of genes related to axonal guidance were also observed in FLT compared to AEM such as GNA13 and KALRN (Lee and Luo, 1999; Mandela et al., 2012), in agreement with the concept of vascular and neural guidance as coordinated processes (Suchting et al., 2006; Eichmann et al., 2005; Park et al., 2003). A significant upregulation of two key genes implicated in reorganization of the cytoskeleton, cell shape, and cell-cell adhesion by desmosomes, guanine nucleotide binding protein (G protein) alpha 13, and desmoplakin (+1.89 and +4.01 fold, respectively) also suggests that remodeling processes were taking placed in the stressed retinas of FLT mice.
In summary, these results bring light to some of the molecular processes taking place in the retina when mice are exposed to spaceflight environmental conditions. While we have highlighted the pathways that may be biologically relevant and correlated with the changes observed in the histomorphology of retinal tissues of animals exposed to spaceflight, this work provides a catalog of differentially expressed genes that can be used to explore various hypotheses related to the pathophysiology of visual alterations in spaceflight and translated to possible ocular implications for human crews in long-duration space exploration missions.